Novo Nordisk CEO Lars Fruergaard Jorgensen has called attention to the complexities of the U.S. healthcare system while ...

L.A. is particularly susceptible to “miracle” cures. And there are some troubling aspects of the Ozempic gold rush that don’t ...

The prescription drug has been all over the news in the past couple of years - but the name Ozempic has become something of a ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

"Their effects on vaginal health are an important consideration that is often overlooked," gynecologist Melanie Bone told Newsweek.

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...

About 165 million Americans rely on employer-sponsored health insurance and yet, workers may still not get the coverage they want — particularly when it comes to drugs like Wegovy and Ozempic.

High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...

Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

Novo Nordisk and Viatris have agreed to resolve a patent dispute related to Novo's blockbuster weight-loss drugs Ozempic and ...

Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...